abstract |
The invention relates to variants and fusions of fibroblast growth factor 19 (FGF19), variants and fusions of fibroblast growth factor 21 (FGF21), fusions of fibroblast growth factor 19 (FGF19) and / or factor 21 of fibroblast growth (FGF21) and protein variants or fusions of fibroblast growth factor 19 (FGF19) and / or fibroblast growth factor 21 (FGF21), and the sequences of peptides (and peptidomimetics), which have a or more activities, such as glucose reduction activity, and methods for and uses in the treatment of hyperglycemia and other disorders. |